Mackenzie Financial Corp Uro Gen Pharma Ltd. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$35.47 - $54.55 $179,123 - $275,477	-5,050 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$38.35 - $50.39 $88,205 - $115,897	-2,300 Reduced 31.29%	5,050 $217,000
Q3 2018 Nov 15, 2018	BUY	$41.65 - $51.7 $306,127 - $379,995	7,350 New	7,350 $347,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.